This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Bos taurus
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
B cell (Raji)
Blood
Breast cancer cell (MCF7)
Breast cancer cells (MDA-MB-231)
Colon cancer cell (HCT116)
Colon cancer cell (HT29)
Colon cancer cell (SW48)
Fetal human colon epithelial cell (FHC)
Liver cancer cells (CSQT-2)
Liver cancer cells (HCC-LM3)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Lung cancer cell (DMS563)
Lung cancer cells (A549)
Mammary gland cells (MCF10A)
Metastatic gastric cancer cell (AZ521)
Oral cancer cells (HOC313-LM)
Oral cancer cells (HOC313-P)
Plasma
Primary dendritic cell
Saliva
Serum
T cell (Jurkat)
By sample status
Cisplatin-resistant
Colorectal cancer_stage1
Colorectal cancer_stage2_after_resection
Colorectal cancer_stage3a_after_resection
Colorectal cancer_stage3b_after_resection
Colorectal cancer_stage4_after_resection
Electroporated with Dicer antibody
Extremely severe hand, foot, and mouth disease
Fetal bovine serum
Healthy_timepoint1
Healthy_timepoint2
Normal
Normal_Exiqon
Oral lichen planus patient
Pancreatic cancer patient_Agilent
Pancreatic cancer patient_Exiqon
Pollen allergy_timepoint1
Pollen allergy_timepoint2
Type 1 diabetes
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.8e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
5.0e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.9e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.8e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.7e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.9e-1
Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
2.4e-6
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
2.6e-5
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
2.4e-8
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
2.4e-8
The human miRNA repertoire of different blood compounds.
BMC Genomics. 2014 Jun 14;15:474. doi: 10.1186/1471-2164-15-474.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.8e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.9e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.9e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.7e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.8e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.9e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.8e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
5.0e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.7e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.3e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
2.3e-2
5.0e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
5.6e-4
4.8e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.5e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.4e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.8e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
2.6e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.2e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
6.4e-2
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
2.0e-1
Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients.
Oral Dis. 2015 Sep 21. doi: 10.1111/odi.12374.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.9e-2
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
7.0e-2
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.1e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
3.2e-1
Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
1.5e-15
1.9e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.5e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
4.3e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
0.0e+0
1.4e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
2.9e-3
2.9e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000419_1
53
/
0
/
53
hsa-miR-574-5p
MIMAT0004795
2.2e-3
2.2e-3
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000419_1
53
/
0
/
53
<
[2]